29 C
Vientiane
Sunday, June 8, 2025
spot_img
Home Blog Page 2672

Superstar Teacher Uses the Latest in AI to Bring Online Learning to the Next Level in the Age of EdTech

SINGAPORE – Media OutReach – 29 November 2021 – Established online learning platform Superstar Teacher is partnering with AI-centred EdTech startup Cerebry to launch a new Artificial Intelligence (AI) Learning Mode to complement their existing library of online lessons. Students can now benefit from tailored questions catered to enhancing their strengths and improving on their shortcomings thanks to the help of AI technology.

 

Superstar Teacher’s online course library is built around topical concepts found in MOE syllabuses and commonly tested exam questions. Questions generated through this new Learning Mode will complement existing lessons while ensuring that students have access to a variety of challenging exercises.

 

Individualised Learning Powered by Artificial Intelligence

 

The questions (and solutions) generated by Superstar Teacher’s AI Learning Mode are automatically generated on the fly, building upon the child’s performance in previous lessons. This means that no two students will receive the same question from the AI system. Additionally, the endless possibility of different questions keeps a student engaged and away from boredom. The system will likewise generate intuitive hints and step-by-step solutions corresponding to the question posed to ensure that the student fully understands the process of getting to the correct answer.

 

Catering to the uniqueness of each child’s learning needs, the AI system has the functionality to create personalised study schedules using diagnostic testing and data-driven insights, focusing on concepts the student appears to be weaker at to remedy all knowledge gaps and attain subject mastery.

 

Efficient and Engaging Revision Plans

 

If the AI system deems that the child does not fully understand a particular concept, they will be brought back to the specific part of the lesson covering this topic in the online course library. From there, the child will be equipped to review their knowledge in particular areas they may have trouble comprehending.

 

Unlike a classroom setting where it would be impossible for a teacher to create a personalised and highly precise study plan for every student, the AI Learning Mode’s real-time feedback enables individual students to work on their knowledge gaps and efficiently target areas of uncertainty with relevant practices. This also ensures that time will be spent effectively. After revision, they will be prompted to return to the AI Learning mode and complete questions to test their understanding. Students will only be able to progress to higher-level topics once they have displayed mastery in foundational topics.

AI-Human Synergy in Optimising Learning

 

With the advancement of AI technologies, there are growing concerns and fears that artificial intelligence will eventually replace human educators. However, Superstar Teacher recognises the importance of the interactive element in human teaching and aims to provide a holistic learning environment driven by both AI learning and human experts. This synergy between self-directed AI-enhanced learning and on-demand feedback from qualified mentors will optimise the learning experience for students.

 

Interested parents can sign their child up for a free trial to experience these features.

 

About Superstar Teacher

Conceptualised in 2011, Superstar Teacher is committed to creating an excellent learning experience for students through quality strategy-based teaching aligned with Singapore’s MOE syllabuses. Its online learning platform is equipped with innovative features and aims at keeping students engaged in the pursuit for academic excellence. For more information, visit www.superstarteacher.com.sg.

#SuperstarTeacher

Laos On Alert for Omicron Covid-19 Variant

Omicron variant

The National Taskforce for Covid-19 Prevention and Control says the country is on high alert for the new Omicron variant.

FIRE FIT To Heat Up UAE Fitness Scene

FIRE FIT announces opening of exciting new boutique fitness concept in Abu Dhabi

ABU DHABI, UAE – Media OutReach – 28 November 2021 – Partners Walid Khoury and Ahmad Alhonjol today announced the completion of an agreement that will bring FIRE FIT’s new and exciting boutique fitness experience to the United Arab Emirates, which is sure to set the local fitness scene alight. Scheduled to open its doors at Marina Square, Reem Island in the first quarter of 2022, the two-studio boutique gym will offer a number of Signature programmes across several modalities including boxing, strength and HIIT training in addition to a specialist personal training studio.

 

FIRE FIT makes its debut in Abu Dhabi as a result of a licensing agreement between Evolution Wellness Group (Evolution Wellness), Asia’s leading fitness and wellness group, and Messrs. Khoury & Alhonjol. The agreement provides exclusive rights to open FIRE FIT boutique gyms throughout Abu Dhabi, beginning with the initial development of a flagship location on Reem Island.

 

Walid Khoury said: “We are delighted to partner with Evolution Wellness Group in this venture and begin our fitness business aspirations. The UAE fitness landscape has experienced substantial growth especially in the last decade, owing to growing awareness and consciousness about the need to lead an active lifestyle not just for good health but for overall quality of life, and we feel that there is a lot of opportunity to add vibrancy to the Abu Dhabi fitness scene.” Ahmad Alhonjol added: “Having been on the lookout for the right experiential boutique fitness concept for some time, the FIRE FIT brand was the only option that ticked every box for us, because it allows us to deliver a range of specialist classes in dedicated studios, all at the one location, meaning we have maximum market appeal. Along with the personal training option, we feel these unique selling points are the perfect opportunity for Abu Dhabi.”

 

“Evolution Wellness is proud to be continuing our growth plans through the realization of licensing strategies for our premium boutique brand by partnering with such a great team in the UAE. The unique FIRE FIT proposition and extensive support structure allows us to successfully scale around the world at rapid pace. The conclusion of our agreement with Ahmad and Walid is just the start of our Middle East expansion,” said Nad Myan, Director of Growth & Innovation, Evolution Wellness.

 

FIRE FIT Abu Dhabi will introduce fitness fans to a number of proprietary Signature programmes, namely:

  • FORCE
  • Forge that body you want with this powerful 45 minutes of strength training and HIIT session. Equipment, bodyweight and whatever it takes to get your muscles working and you walking out stronger, bolder. Class format has all participants performing the same moves at the same time with heart rate data feedback.

  • STRIKE
  • Fight club meets night club. It’s all the power of old school kickboxing, drilled and skilled in a high-energy, high intensity group atmosphere. So tick off that cardio workout and FIRE off that stress relief in just one 45-minute session. Each participant works on their own bag for the entire session with both bag data and heart rate performance feedback.

  • REVOLUTION
  • Ignite a real change with FIRE Revolution. We’ve tailored this 45-minute high-intensity programme to help you spark your FIRE with 3 fiery boosts. First off, the tech. At Revolution, you’ll work out with our smart fitness reader that accurately tracks your heart rate and your progress. Secondly, no class is ever the same. Each time you show up, it’s a different workout to get you fired up. Lastly, you’re never alone. REVOLUTION is all about the community, grinding and sweating together. With a combo like that, there’s no doubt you’ll have a blazing time.

For more information about FIRE Fit Abu Dhabi, please visit https://www.firefitstudios.ae/.

For more information about the FIRE Fit licensing programme, please visit https://bit.ly/FIREFITInvest2021.

 

About FIRE Fit

FIRE Fit aspires to be the world’s hottest boutique gym brand whose workouts promise to fire you up so you can take on life’s challenges with guns blazing. Our inspiring Rockstar trainers deliver some of the most innovative fitness class experiences within a boutique gym environment in the market today, designed to forge, sculpt and shape everybody. Start living a life on FIRE – visit https://www.firefitstudios.ae/

The FIRE Fit brand is owned by Evolution Wellness Group, Asia’s leading health and wellness group, and is available to license. Enquire at https://www.firefitgroup.com

About Evolution Wellness Group

Established in 2017, Evolution Wellness is Asia’s leading health and wellness group with a vision to build a comprehensive wellness ecosystem. Its diverse portfolio of highly complementary brands spans the spectrum of fitness offerings from high value low price (HVLP), to full service and premium boutique gyms, virtual fitness, connected fitness, wellness and a subscription-based SaaS membership management system.

Besides its core business as owner and operator of Asia’s largest network of wholly- owned fitness clubs, Evolution Wellness also offers an attractive licensing programme for its HVLP brand GoFit and premium boutique brand FIRE Fitness, joint venture opportunities and management consultancy for its wellness brand, Fivelements.

For more information about Evolution Wellness, portfolio brands, and services, please visit www.evolutionwellness.com.

#FIREFit #EvolutionWellness

Thailand to Open Nong Khai Land Border With Laos Next Month

Nong Khai reports case of Covid-19


Thailand has further eased entry regulations for travelers from abroad, including arrivals by land at the Nong Khai border checkpoint.

Laos Confirms 1,195 New Cases of Covid-19 and Five New Deaths

Covid-19 Update for Laos
Covid-19 Update for Laos


Laos has recorded 1,195 new cases of Covid-19 across the country today, with five new deaths attributed to the virus, including a 27-year-old five months into pregnancy.

SunMirror AG: Shares have been admitted to trading on the Official Market (Amtlicher Handel) of the Vienna Stock Exchange

First day of trading will be on 29 November 2021

ZUG, SWITZERLAND – EQS Newswire – 27 November 2021 – The Vienna Stock Exchange (Wiener Börse) today approved the application of SunMirror AG (“SunMirror”; Vienna Stock Exchange: ROR1; Düsseldorf Stock Exchange: ROR; ISIN CH0396131929) for admission of its shares to trading on the Official Market (Amtlicher Handel), segment Standard Market Continuous, a Regulated Market under the EU MiFID II Directive.

The first day of trading of the shares of SunMirror on the Official Market will be on 29 November 2021.

Trading of the shares of SunMirror in the Vienna MTF of the Vienna Stock Exchange will end on the trading day before the first day of trading on the Official Market.


For the time being, the shares of SunMirror will continue to be listed and traded on the unofficial market segment (Freiverkehr) of the Düsseldorf Stock Exchange (Börse Düsseldorf), a multilateral trading facility (MTF) under the EU MiFID II Directive, as before.


The issuer is solely responsible for the content of this announcement.


About SunMirror AG

The Group invests into pre-production mineral exploration assets with a focus on battery metals, iron ore and gold deposits in developed markets for the purpose of evaluation and exploration with the aim to either produce minerals at a later stage or sell those properties. The company’s shares (ISIN CH0396131929) are listed on the Vienna Stock Exchange (ticker: ROR1) and the Düsseldorf Stock Exchange. For further information, please visit: www.sunmirror.com.

#SunMirror

Jacobson Pharma Announces FY2022 Interim Results

Robust Growth of 11.6% in Generics Business Amidst the Pandemic; Confident about Sustaining Strong Growth Momentum

Declares Interim Dividend of HK1.2 Cents Per Share; A 50% Growth Compared to FY2021 Interim

 

HONG KONG SAR – Media OutReach – 26 November 2021 – Jacobson Pharma Corporation Limited (“Jacobson Pharma” or the “Company”; Stock Code: 2633), a leading company engaging in the research, development, production, marketing and sale of essential medicines, specialty drugs and branded healthcare products, today announced the interim results of the Company and its subsidiaries (collectively the “Group”) for the six months ended 30 September 2021 (the “Reporting Period”).

 

Backed by the gradual recovery of both Public and Private Sectors for its generic drugs business alongside the stabilisation of COVID-19 pandemic in Hong Kong, the Group delivered total revenue of approximately HK$750.4 million, which represented a 7.9% growth during the Reporting Period. The profit from operations reached HK$116.9 million while profit for the period was recorded at HK$82.9 million, both with a considerable growth of about 28.5% and 46.2% respectively, as compared to the adjusted profit from operations* and adjusted profit for the period* ended 30 September 2020.

 

The Group maintains a healthy financial position as supported by its strong cash flows, with adjusted earnings before interest, taxes, depreciation and amortisation (adjusted EBITDA) of HK$203.9 million for the Reporting Period such that the net gearing ratio decreased significantly from 38.4% as of 31 March 2021 to 27.7% as at the end of the Reporting Period. In addition, the Group has a strong cash position, with cash balance of HK$537.1 million as at the end of the Reporting Period. The Board has resolved to declare an increased interim dividend by 50% to HK1.2 cents per share for the six months ended 30 September 2021 (FY2021 Interim: HK0.8 cent).

Resilience Performance of Generic Drugs Business

The generic drugs business of the Group recorded revenue of HK$562.2 million (FY2021 Interim: HK$503.8 million) in the Reporting Period, which represented a steady growth of 11.6%. This was driven by the stable and solid growth of 9.3% in its Public Sector, along with a notable recovery of its Private Sector delivering growth at 13.8%.

Although there was a slow down in medication demand of common cold and flu drugs during the pandemic due to social distancing measures and face mask wearing practice, medications for the aging population and chronic disease patients continue to exhibit a strong demand. For instance, among the Group’s cardiovascular offerings, the angiotensin II antagonist class and lipid-lowering product class recorded a notable growth of 34.4% and 27.7% in sales respectively during the Reporting Period, generated by new businesses secured for Losartan Tablets and Rosuvastatin Tablets as well as the continuous increase in consumption of anti-hypertensive drugs such as Perindopril Tablets in the Public Sector.

 

Furthermore, the Group’s therapeutic sectors of psoriasis preparations and attention deficit hyperactivity disorder drugs (ADHD) also exhibited robust growth of 328.1% and 88.8% respectively, due to new public tenders awarded in the Public Sector. During the Reporting Period, the Group also secured first-time public tenders, which included Atosiban Injection, Idarubicin Injection, Quetiapine Extended Release Tablet 200mg, as well as Haloperidol Tablets 5mg and 10mg. The Group’s antiulcer drugs and anti-hypertensive class products also delivered strong growths of 24.2% and 88.0% respectively in the Private Sector.

 

As a continuous drive for portfolio enhancement, the Group launched a number of new products during the Reporting Period, including Antisob Injection, Indarubicin Injection, Acitretin Capsule, Atomoxetine Capsule, Finasteride Tablet, Homatropine Eye Drops, Ofloxacin Eye Drops and Ear Drops. Additionally, the Group has secured the registration approvals for a group of new products such as Febuxostat Tablet, Brimonidine and Timolol Eye Drops, Olmesartan Tablet and Telmisartan and Hydrochlorothiazide Tablet for upcoming market launches.

In addition to its research and development (“R&D”) pipeline, the Group also signed exclusive in-license agreements for 4 specialised drugs of the central nervous system (CNS) and immunomodulatory classes from Europe.

 

Stable Performance of Branded Healthcare Business

The Group’s subsidiary in consumer branded healthcare, JBM (Healthcare) Limited (Stock Code: 2161), recorded revenue of HK$188.2 million during the Reporting Period, a soft decline of 1.8%. The decline was mainly attributable to the sluggish consumer demand in both domestic and certain overseas markets caused by the COVID-19 pandemic.

 

Distribution of Fosun BioNTech Comirnaty Vaccine in Hong Kong and Macau

The Group is the exclusive distributor of Fosun BioNTech Comirnaty Vaccine (the “Vaccine”) in Hong Kong and Macau. The vaccination programme started in Hong Kong on 10 March 2021, and up to the end of the Reporting Period, the Group had delivered a total of 6.9 million doses of the Vaccine to the Department of Health and community vaccination centers in Hong Kong as well as the Macau government. Jacobson Pharma will continue to collaborate with Shanghai Fosun Pharmaceutical (Group) Co., Ltd. on supplying the third vaccination doses for the public if the booster shot is deemed necessary by the health authorities.

 

Mr. Derek Sum, Chairman and Chief Executive Officer of Jacobson Pharma, concluded, “The unprecedented impact of COVID-19 has rippled across Hong Kong’s economy and taken its toll since the beginning of 2020. Amid the tough market environment, we were committed to maintaining stable business development. This was achieved in part by virtue of the Group’s diversified product portfolio, with generic drugs in particular showing continuous and resilient growth driven by the increasing prevalence of chronic diseases and the aging population in Hong Kong. Our persistent efforts in maximising the commercial opportunities of our portfolio of offerings, strengthening our product pipelines through in-licensing and in-house R&D have helped us endure market challenges, as well as laying a solid foundation for healthy business development in coming days.

 

We are confident that the challenges of the pandemic are largely behind us and that the growth momentum will continue into the second half of FY2022, thus taking the Group’s business to the next level. We will continue to leverage our strengths in R&D capabilities as well as sales and distribution network, to seize market opportunities and drive the stable business development of Jacobson Pharma.”

About Jacobson Pharma Corporation Limited (雅各臣科研製藥有限公司;Stock Code: 2633)

Jacobson Pharma is a leading pharmaceutical company in Hong Kong vertically integrated with the research, development, production, sale and distribution of essential medicines and specialty drugs. As a major provider of generic drugs in Hong Kong, the Group has one of the most extensive sales and distribution coverage for both the private and public market sectors in Hong Kong, with an expanding reach into strategically selected Asian markets. Carrying a broad product portfolio and taking a pre-eminent market position in a number of therapeutic categories, the Group operates a host of 10 PIC/S GMP licensed production facilities for generic drugs in Hong Kong.

The Group aims at the continued strategic enrichment of its generic drug portfolios through the addition of high value-added products. With its corporate headquarters based in Hong Kong, the Group has also established its operating subsidiaries in China, Macau, Taiwan, Singapore and Cambodia forming a regional commercial platform to tap the market potential in the Asia Pacific and Greater China region. Jacobson Pharma has been a constituent stock of MSCI Hong Kong Micro Cap Index since 1 June 2017. For more details about Jacobson Pharma, please visit the Group’s website: http://www.jacobsonpharma.com

#JacobsonPharma

HONMA Golf Announces Robust FY2021/22 Interim Results for the Six Months ending Sep 30, 2021

  • Half year sales of JPY 11,872 million, up 31.1% and 12.1% versus same period of FY2020 and FY2019 respectively
  • EBITDA increased by 4.6 times to JPY 2,635 million as compared to same period last year
  • Interim dividend of JPY 1.5 per share

HONG KONG SAR – Media OutReach – 26 November 2021 – HONMA Golf Limited (“HONMA” or the “Group”; together with its subsidiaries, the “Group”; HKEx stock code: 6858), one of the most prestigious and iconic brands in the golf industry, is pleased to announce its consolidated results for the six months ended 30 September 2021 (the “Period”).

 

Record sales growth driving visible improvements in all financial metrics

During the Period, the Group delivered robust growth across most of its markets and product categories, resulting in positive and visible improvements in key financial metrics.

 

Net sales were JPY 11,872.0 million (equivalent to USD106.8 million) during the Period, representing a significant increase of 31.1% and 12.1% as compared with the same period of FY2020 and FY2019 respectively, marking a full recovery from the negative impact of Covid-19.

 

Geographically, Japan and China led the way in terms of growth and rose by 105.9% and 54.0% respectively, while North America, Europe and Rest of the World[1] followed the way with double digit growths.

 

All product categories showed double if not triple-digit growth across the board, where apparel grew by 151.3% and golf clubs by 23.9% compared to the same period last year. The Group also made continued inroads into performance club and non-club product categories thanks to steadfast execution of growth strategies by our global teams.

 

During the Period, the Group’s gross profit margin climbed up by 4.1 percentage points to 55.3%, despite strong supply chain headwinds.

 

Profit before tax was JPY 1,746.5 million (equivalent to USD15.7 million), up from a loss of JPY 431.4 million for the same period last year. Operating cash flow remained strong, expanding by 43.7% to JPY 3,702.4 million (equivalent to USD33.3 million) in the Period.

 

The Board proposed an interim dividend of JPY 1.5 per share, amounting to a total of JPY 908.5 million for the six months ended 30 September 2021, representing 67.3% of the Group’s distributable profits for the Period.

 

Most markets demonstrated vigorous growth at full throttle

Geographically, Japan demonstrated the greatest growth, pushing up sales by 105.9% to JPY 3,821.6 million (equivalent to USD 34.4 million), on the back of a complete sales recovery in all channels and product categories. Another home market, China, continued to deliver solid performance, presenting a year-on-year sales growth of 54.0% to JPY 3624.7 million (equivalent to USD 32.6 million), driven by continued expansion of the Group’s retail footprint and optimization of its product lineup.

 

Similarly, sales from North America, Europe and Rest of the World also increased significantly by 40.7%, 29.2% and 30.0% respectively. Following a gradual easing of government-imposed social distancing rules, HONMA resumed distribution network expansion in North America and Europe and added 100 and 37 net points of sales (“POS”) respectively, in response to growing increase in golf participation in these markets and enhanced brand awareness.

 

South Korea fell however, below same period last year with sales declining by 31.0% to JPY 2,149.8 million (equivalent to USD 19.3 million), due to unexpected component shortfall. Up to the reporting date, such constraints have been substantially relieved and shipments are expected to resume from December 2021.

 

All product categories recorded double if not triple digit growth

Thanks to continued product development efforts and continued market penetration, the Group achieved outstanding sales growth across all product categories. The Group now offers a complete golf lifestyle experience through its extensive range of HONMA-branded golf clubs, golf balls, apparel and other accessories.

 

HONMA continued to focus on club products that best represent traditional Japanese craftsmanship and innovative technology to tailor to players in the super-premium and premium-performance segments. In January 2021, HONMA launched its second performance enhancement club set, the GS series, targeting avid golfers of 8-20 handicaps. With deeper penetration into the performance club segment, sales from golf clubs, which account for 73.4% of the Group’s total sales, increased by 23.9% to JPY 8,719.4 million (equivalent to USD 78.5 million) as compared to the same period last year, reaffirming HONMA’s strong brand equity and its continuous ability to withstand economic challenges since it started in the golf business back in 1959.

 

Beyond clubs, HONMA has been continuously nurturing its non-club business in Asia home markets as an important pillar of its growth strategies.

 

Sales of apparel increased by 151.3% to JPY 1,259.3 million  (equivalent to USD 11.3 million) during the Period, accounting for 10.6% of total sales, thanks to continued investment in product development, optimization of merchandise planning and improved retail operations. With this, apparel overtook balls and accessories to become the second largest product category of HONMA, the first time since its re-launch in Spring 2019.

 

Revenue from golf balls grew steadily by 24.3% to JPY 1,153.7 million (equivalent to USD 10.4 million) during this period hence delivering a CAGR of 41.1% over the last six years. The Group further utilized its leading R&D capabilities and launched ball products pivoting a pyramid product strategy while continuously gaining mind and market share.

 

Extended retail presence with increased same-store-sales (“SSS”) and surging e-commerce sales

During the Period, the Group further expanded HONMA’s retail presence through location optimization, elevated visual design and merchandising display to provide better consumer experiences.

 

HONMA operates the largest number of self-operated stores among major golf companies, providing consumers with a 360-degree experience of the HONMA brand and its products. During the Period, the number of HONMA’s self-operated stores dropped slightly by 3 to 77, while sales grew by 34.6% to JPY 3,516.1 million , demonstrating visible SSS growth.

 

Sales from third-party retailers and wholesalers increased by 29.7% to JPY 8,355.9 million (equivalent to USD 75.2 million) for the Period as retail operation stablized after Covid-19. In particular, sales to the Group’s retail partners in Japan grew by 265.3% as most retailers recovered from extended and lingering business closure during the pandemic. Total POS in all markets increased by 182 to 4,117 by the end of the Period.

 

It is worth noting that sales from the Group’s e-commerce channels jumped by 99% during the Period. The Group currently operates e-commerce channels in China, Japan, South Korea and the US and all these markets reported record sales results during the Period, led by sales growth from China of 114.9%. During the most recent 2021 ‘Double 11’ e-commerce campaign in China, total GMV from HONMA’s Tmall and JD flagship stores more than doubled compared with the same period last year. Such robust growth was fuelled by accelerated digital marketing efforts, in particular content marketing and full-channel approach, executed by dedicated e-commerce teams. The Group has seen continued momentum in e-commerce driven by profound and accelerated change in consumer behaviour and business environment through digital transformation.

 

Re-defining the HONMA brand

The Group made further efforts to improve its global brand positioning and its communication and engagement with existing and potential consumers in the super premium and premium performance segments, with a view to re-define HONMA as a premium, dynamic, modern and global brand through the 360-degree HONMA experience in retail stores, dedicated customer events and topical digital content. HONMA has been proactively engaging with younger internet-savvy golfers by regularly updating its global website and social media platforms.

 

Through continuous efforts in recent years, HONMA has gained strengthened brand awareness and recognition in the global golf community. In September 2021, HONMA was featured by CNN Living Golf in its Tokyo Olympics episode, showcasing HONMA’s more than 60 years of dedication towards premium club development.

 

Business Outlook

With the global easing of Covid-19 related restrictions, the golf industry has seen a speedy recovery and continued increase in participation and purchase interest worldwide. HONMA has observed pent-up demand to play golf, a visible increase in new and returning golfers and an uptick in new orders from both end consumers and retailers. The Group fully expects the golf industry to settle into the new environment.

 

Moving forward, the Group will continue to execute its long-term growth strategy to build a world-leading golf lifestyle business by leveraging HONMA’s brand legacy, expanding its distribution network, innovative technologies and traditional Japanese craftsmanship. In the face of continued uncertainty posed by the Covid-19 pandemic, the Group will continue to take proactive action to optimize cost, maximize liquidity and protect the health of its employees.

 

The Group will also continue to transform its brand values into customer loyalty, with the exclusive brand experience through its self-operated stores forming the centerpiece of HONMA’s new consumer touchpoints and acting as hubs to generate traffic to HONMA’s extensive shop-in-shops, third-party retailers, golf courses and online e-commerce platforms. The Group will further increase market share in its biggest markets of Japan, South Korea and China by maintaining its leading position in the super-premium segment while making solid inroads into the fast-growing premium-performance segment, and at the same time striving to pivot growth in North America and Europe based on updated products and a direct-to-consumer (DTC) distribution strategy. In terms of products, the Group will continue to nurture complementary non-club product lines to provide customers with a complete golf lifestyle experience, as well as push forward product innovation and development to cater to the latest market trends.

 

Mr. LIU Jianguo, Chairman of the Board, President and Executive Director of HONMA Golf Limited, said, “We have seen a significant ramp-up of interest worldwide in playing golf, purchasing golf products and participating in the industry. Our global HONMA teams have spared no efforts to seize the opportunities and achieved excellent results across all product lines in most of our markets. Although challenges remain, especially with the pandemic continuing to affect mobility and supply chains and with global inflationary pressures, we are positive that our efforts will outpace the headwinds as we forge ahead with our growth strategies.”

 



[1]  “Rest of the World” refers to the markets HONMA operates in, excluding Japan, South Korea, Mainland China and Hong Kong, North America and Europe

About HONMA Golf Limited

HONMA is one of the most prestigious and iconic brands in the golf industry. Founded in 1959, the Group utilizes the latest innovative technologies and traditional Japanese craftsmanship to provide golfers around the world with premium, high-tech and the best performing golf clubs, balls, apparels and accessories. HONMA’s products are sold in approximately 50 countries worldwide, primarily in Asia and across North America, Europe and other regions. The Group was successfully listed on the Main Board of The Stock Exchange of Hong Kong Limited on 6 October 2016 (SEHK stock code: 6858). As the only vertically integrated golf Group with in-house design, development and manufacturing capabilities, a strong retail footprint in Asia and a diverse range of golf clubs and golf-related products, HONMA is perfectly positioned to continually grow its business in Asia and beyond, benefitting from the return of golfers in mature golf markets such as the US and Japan and from increased participation in golf’s new and under-penetrated markets such as Korea and China.

#HONMA